5/29
08:12 am
eols
AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan [Yahoo! Finance]
Low
Report
AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan [Yahoo! Finance]
5/22
06:04 pm
eols
Over 130 Resident Dermatologists Receive In-Depth Cosmetic Training From Renowned ASDS Member Physicians [Yahoo! Finance]
Medium
Report
Over 130 Resident Dermatologists Receive In-Depth Cosmetic Training From Renowned ASDS Member Physicians [Yahoo! Finance]
5/22
07:04 am
eols
Evolus: Chiseling Away At The Aesthetic Market [Seeking Alpha]
Low
Report
Evolus: Chiseling Away At The Aesthetic Market [Seeking Alpha]
5/21
12:11 pm
eols
Evolus (EOLS) Releases Favorable Dermal Fillers Study Data [Yahoo! Finance]
Low
Report
Evolus (EOLS) Releases Favorable Dermal Fillers Study Data [Yahoo! Finance]
5/21
08:03 am
eols
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Medium
Report
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
5/20
08:42 am
eols
Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting [Yahoo! Finance]
Low
Report
Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting [Yahoo! Finance]
5/20
08:30 am
eols
Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting
Medium
Report
Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting
5/15
08:39 am
eols
Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women's Wear Daily Beauty CEO Summit [Yahoo! Finance]
Low
Report
Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women's Wear Daily Beauty CEO Summit [Yahoo! Finance]
5/15
08:30 am
eols
Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO Summit
Medium
Report
Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO Summit
5/14
04:16 pm
eols
AEON Biopharma Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
AEON Biopharma Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/10
06:55 pm
eols
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/10
09:10 am
eols
Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
Low
Report
Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
5/8
03:33 pm
eols
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Low
Report
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
5/8
11:24 am
eols
Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/8
08:07 am
eols
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Low
Report
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
5/7
04:19 pm
eols
Evolus Reports First Quarter 2024 Results and Provides Business Update [Yahoo! Finance]
Low
Report
Evolus Reports First Quarter 2024 Results and Provides Business Update [Yahoo! Finance]
5/7
04:05 pm
eols
Evolus Reports First Quarter 2024 Results and Provides Business Update
Low
Report
Evolus Reports First Quarter 2024 Results and Provides Business Update
5/3
11:34 am
eols
The 15% return this week takes Evolus' (NASDAQ:EOLS) shareholders one-year gains to 59% [Yahoo! Finance]
Low
Report
The 15% return this week takes Evolus' (NASDAQ:EOLS) shareholders one-year gains to 59% [Yahoo! Finance]
5/1
09:23 am
eols
Board Certified Celebrity Dermatologist Dr. Ava Shamban Launches Althaea Skin [Yahoo! Finance]
Medium
Report
Board Certified Celebrity Dermatologist Dr. Ava Shamban Launches Althaea Skin [Yahoo! Finance]
5/1
04:17 am
eols
Green Thumb Industries Inc. (GTBIF) Surges 22.3%: Is This an Indication of Further Gains? [Yahoo! Finance]
Medium
Report
Green Thumb Industries Inc. (GTBIF) Surges 22.3%: Is This an Indication of Further Gains? [Yahoo! Finance]
4/23
04:30 pm
eols
Evolus to Report First Quarter Financial Results on May 7, 2024
Low
Report
Evolus to Report First Quarter Financial Results on May 7, 2024
4/17
04:19 pm
eols
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau® [Yahoo! Finance]
Low
Report
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau® [Yahoo! Finance]
4/17
04:05 pm
eols
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
Low
Report
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
4/16
07:18 pm
eols
Counterfeit Botox has been found in several states. Here's what consumers should know. [CNN]
Low
Report
Counterfeit Botox has been found in several states. Here's what consumers should know. [CNN]
4/16
04:35 pm
eols
Counterfeit Botox has been found in several states. Here's what consumers should know. [CNN]
Low
Report
Counterfeit Botox has been found in several states. Here's what consumers should know. [CNN]